Rodrigo A. Sierra’s Post

CCTT member Rodrigo A. Sierra, CCO and SVP of American Medical Association, and his team recently had a case study published in the Journal of Contingencies and Crisis Management. This case study, titled “The art and science of de-weaponizing disinformation for the public good,” discussed how to best manage disinformation in the wake of the pandemic and how to effectively and ethically communicate with the public. Read more at https://lnkd.in/eSeQHEAJ

Thomas H. Gallagher, M.D., Collaborative for Accountability and Improvement and Allen Kachalia, M.D., J.D., Johns Hopkins Armstrong Institute for Patient Safety and Quality write about their support for communication and resolution programs, also known as CRPs, in a new perspective: https://buff.ly/3Hk6mWa NEJM Group Here in Massachusetts, the Betsy Lehman Center is implementing a CRP model known as Communication, Apology, and Resolution (CARe). Learn more about the benefits of CARe and how to get involved: https://buff.ly/3Hpqlmq

Based on a recent webinar of ours, we're excited to share a new video series: 10 Things You Didn't Know About a Virtual Site. In today's clip, listen to Science 37 Chief Medical Officer and Principal Investigator Dr. Jonathan Cotliar cover how our virtual site model (Metasite™) works in a clinical trial. Watch the full webinar video here: https://lnkd.in/eU_vXT8J #clinicalresearch #clinicaltrials #clinicalstudies #virtualtrials #virtualsite

If you've wondered what a Communication and Resolution Program is or why it's important for a healthcare organization to have one, please read this great new article in the New England Journal of Medicine!

What is the percentage of clinicians that participate actively in research? Do clinicians conduct research only when absolutely necessary (for example when it’s a requirement to pass an exam)? What are the barriers that prevent clinicians from participating in research? These and much more will be explored in our upcoming session with Dr Oladimeji Adebayo. Join us on the 🗓️2nd of Novemeber, 2024 by 🕰️8am (GMT+1) as we explore “Overcoming Barriers to Research Participation Among Clinicians”. Register for the session via🔗 https://bit.ly/4hkjrzv

Last day to register! Join us for an insightful conversation with TRANSFORM study chair Deepak L. Bhatt, MD, MPH, MBA along with Cleerly founder and CEO James Min, MD, Chief Medical Officer James P Earls MD, FSCCT, and Chief Scientific Officer Udo Hoffmann MD MPH. Learn about this ambitious trial that aims to show how CCTA with AI-analysis can revolutionize how we approach MACE prevention. https://cleer.ly/TCC8L

#DrDavidBrenner of Columbia University, discusses the work that he and other scientists have done over the last several years around the effects of Far-UVC light for the potential benefit of public health. We are honored to have him on Lit Thinking's Science Advisory Board. 👏 Learn how Far-UVC technology is creating safer and healthier spaces for all. https://lnkd.in/gXdAM7B7

With Science 37's Virtual Site, clinical trial participants can remain at home and do not need to travel to a physical site. But, you may be wondering, how are physical exams and adverse events (AE) managed? VP of Internal Medicine, Dr. Debra Weinstein, explains in this video. Watch the full "10 Things You Didn't Know About a Virtual Site" webinar recording here: https://lnkd.in/eCNUFFzR #clinicalresearch #clinicaltrials #clinicalstudies #virtualtrials #virtualsite #patientrecruitment

Stellus Rx pharmacy support not only helps patients, but helps their physician practices as well. Read the article below to hear first-hand from a physician partnered with Stellus Rx, Dr. Stephen Buksh.

Chief Medical Officer for Data and Research, Dr Lucy Mackillop digs further into the recent report from Newmarket Strategy in her latest blog, which explores the crucial role that primary care plays in clinical research. Read the blog on our website: https://okt.to/DkqcwM